Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - Gemini Therapeutics, Inc. /DE | fs12020_fsdevelopmentcorp.htm |
| EX-99.6 - CONSENT OF DEEPA PAKIANATHAN - Gemini Therapeutics, Inc. /DE | fs12020ex99-6_fsdevelopment.htm |
| EX-99.5 - CONSENT OF DANIEL DUBIN - Gemini Therapeutics, Inc. /DE | fs12020ex99-5_fsdevelopment.htm |
| EX-99.4 - CONSENT OF ROBERT CAREY - Gemini Therapeutics, Inc. /DE | fs12020ex99-4_fsdevelopment.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1, of our report dated July 24, 2020, relating to the balance sheet of FS Development Corp. as of June 30, 2020, and the related statements of operations, changes in stockholder’s equity and cash flows for the period from June 25, 2020 (inception) through June 30, 2020, and to the reference to our Firm under the caption “Experts” in the Prospectus.
| /s/ WithumSmith+Brown, PC | |
| New York, New York | |
| July 24, 2020 |